Published in Am J Cancer Res on May 01, 2011
Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. Nat Nanotechnol (2016) 0.93
Improving Nanoparticle Penetration in Tumors by Vascular Disruption with Acoustic Droplet Vaporization. Theranostics (2016) 0.76
IMART software for correction of motion artifacts in images collected in intravital microscopy. Intravital (2015) 0.75
Optimization of the dorsal skinfold window chamber model and multi-parametric characterization of tumor-associated vasculature. Intravital (2014) 0.75
Dorsal skinfold chamber models in mice. GMS Interdiscip Plast Reconstr Surg DGPW (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
A global double-fluorescent Cre reporter mouse. Genesis (2007) 17.86
Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer (2002) 17.49
Microenvironmental regulation of metastasis. Nat Rev Cancer (2008) 15.76
Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer (2009) 14.17
A perspective on cancer cell metastasis. Science (2011) 13.31
The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev (1989) 13.15
Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr Biol (1998) 8.12
Intravital imaging of cell movement in tumours. Nat Rev Cancer (2003) 6.35
The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer (2005) 5.83
Parallel progression of primary tumours and metastases. Nat Rev Cancer (2009) 5.55
The metastatic niche: adapting the foreign soil. Nat Rev Cancer (2009) 5.28
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci U S A (1996) 5.04
AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res (2010) 4.89
Intravital imaging of metastatic behavior through a mammary imaging window. Nat Methods (2008) 4.13
Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res (1994) 3.84
Illuminating the metastatic process. Nat Rev Cancer (2007) 3.80
Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res (1992) 3.77
Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res (1997) 3.67
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54
Co-evolution of tumor cells and their microenvironment. Trends Genet (2008) 3.08
The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu Rev Cell Dev Biol (2005) 2.97
Tumor-stroma interactions. Curr Opin Genet Dev (2005) 2.89
Optical imaging: current applications and future directions. J Nucl Med (2007) 2.84
Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol (1993) 2.60
Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation (2010) 2.53
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol (2005) 2.43
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res (2000) 2.39
Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res (2009) 2.34
Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol (2000) 2.28
Microenvironmental regulation of cancer development. Curr Opin Genet Dev (2008) 2.25
Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer (2004) 2.20
In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res (2007) 2.19
Genomic alterations in tumor stroma. Cancer Res (2009) 2.18
Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development. Cancer Res (2007) 2.04
Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. Prostate (1998) 2.02
Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res (1997) 2.00
Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res (1996) 1.86
Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res (2004) 1.76
A novel rodent mammary window of orthotopic breast cancer for intravital microscopy. Microvasc Res (2003) 1.69
A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J Clin Invest (2006) 1.62
Cancer dissemination--lessons from leukocytes. Dev Cell (2010) 1.46
The lethal phenotype of cancer: the molecular basis of death due to malignancy. CA Cancer J Clin (2007) 1.46
Whole-body optical imaging in animal models to assess cancer development and progression. Clin Cancer Res (2007) 1.41
Intravital microscopy: new insights into metastasis of tumors. J Cell Sci (2011) 1.36
Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest (2010) 1.32
Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin Cancer Res (2002) 1.29
Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Adv Cancer Res (2007) 1.25
Viewing the microcirculation through the window: some twenty years experience with the hamster dorsal skinfold chamber. Eur Surg Res (2002) 1.22
Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin. Anticancer Res (2000) 1.21
CXCR4 regulates the early extravasation of metastatic tumor cells in vivo. Neoplasia (2009) 1.21
In vivo imaging of tumors. Cold Spring Harb Protoc (2010) 1.13
Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC. Int J Cancer (2000) 1.12
Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy. Methods Mol Med (2005) 1.04
Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation. Br J Pharmacol (2006) 1.03
Intravital imaging and cell invasion. Methods Enzymol (2007) 1.02
Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications. Oncologist (2000) 1.02
Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection. BMC Cancer (2010) 1.00
Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice. Int J Cancer (2005) 1.00
Mapping of angiogenic markers for targeting of vectors to tumor vascular endothelial cells. Cancer Gene Ther (2007) 1.00
Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins. Clin Exp Metastasis (2008) 0.99
Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature. Int J Cancer (2004) 0.97
Optical small animal imaging in the drug discovery process. Biochim Biophys Acta (2010) 0.96
Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor. Pancreas (2002) 0.96
Advances in optical imaging and novel model systems for cancer metastasis research. Clin Exp Metastasis (2007) 0.95
Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin. Clin Cancer Res (2008) 0.94
Pre-conditioning cryosurgery: cellular and molecular mechanisms and dynamics of TNF-α enhanced cryotherapy in an in vivo prostate cancer model system. Cryobiology (2010) 0.94
A selective tumor microvasculature thrombogen that targets a novel receptor complex in the tumor angiogenic microenvironment. Cancer Res (2005) 0.93
Recent advances in metastasis research. Curr Opin Genet Dev (2008) 0.92
Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes. Int J Cancer (2008) 0.92
Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration. Microvasc Res (2005) 0.91
Enhanced tumor suppression by a p14ARF/p53 bicistronic adenovirus through increased p53 protein translation and stability. Cancer Res (2003) 0.91
Revascularization of transplanted adipose tissue: a study in the dorsal skinfold chamber of hamsters. Ann Plast Surg (2002) 0.90
Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth. Proc Natl Acad Sci U S A (2010) 0.90
Translating the metastasis paradigm from scientific theory to clinical oncology. Clin Cancer Res (2009) 0.89
The dorsal skinfold chamber: studying angiogenesis by intravital microscopy. Methods Mol Biol (2009) 0.89
Real time in vivo quantitation of tumor angiogenesis. Methods Mol Med (2003) 0.89
Apoptosis and leucocyte-endothelium interactions contribute to the delayed effects of cryotherapy on tumours in vivo. Arch Dermatol Res (2002) 0.88
Microcirculatory parameters measured in subcutaneous tissue of the mouse using a novel dorsal skinfold chamber. Microvasc Res (2004) 0.86
Application of intravital microscopy in studies of tumor microcirculation. J Biomed Opt (2010) 0.86
Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer. Pancreas (2010) 0.86
A novel method for follow-up studies of the microcirculation in non-malignant tissue implants. Res Exp Med (Berl) (1986) 0.85
Cooperative effect between immunotherapy and antiangiogenic therapy leads to effective tumor rejection in tolerant Her-2/neu mice. Cancer Res (2003) 0.85
Quantitative angiogenesis in a syngeneic tumor spheroid model. Microvasc Res (1995) 0.85
Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo. Prostate (2010) 0.84
Early origin of cancer metastases: dissemination and evolution of premalignant cells. Cell Cycle (2008) 0.82
Static magnetic fields impair angiogenesis and growth of solid tumors in vivo. Cancer Biol Ther (2009) 0.82
Breast cancer metastasis progression as revealed by intravital videomicroscopy. Expert Rev Anticancer Ther (2006) 0.81
Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo. Cancer Sci (2003) 0.78
Real-time subcellular imaging in live animals: new visible targets for cancer drug discovery. IDrugs (2006) 0.77
The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model. Br J Cancer (2010) 0.76
The roles of epithelial-mesenchymal interactions and the innate immune response on the tumorigenicity of human prostate carcinoma cell lines grown in immuno-compromised mice. In Vivo (2003) 0.76
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54
Survey of differentially methylated promoters in prostate cancer cell lines. Neoplasia (2005) 1.63
Pre-morbid skin changes in patients with cancer: Using 'Welam's sign' as a new prognostic marker? Int J Palliat Nurs (2009) 1.38
Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice. Int J Cancer (2005) 1.00
Bile acids mimic oxidative stress induced upregulation of thioredoxin reductase in colon cancer cell lines. Carcinogenesis (2002) 0.99
Combinatorial mRNA binding by AUF1 and Argonaute 2 controls decay of selected target mRNAs. Nucleic Acids Res (2013) 0.99
Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration. Microvasc Res (2005) 0.91
"Promoter array" studies identify cohorts of genes directly regulated by methylation, copy number change, or transcription factor binding in human cancer cells. Ann N Y Acad Sci (2005) 0.91
Enhanced microarray performance using low complexity representations of the transcriptome. Nucleic Acids Res (2005) 0.90
Real time in vivo quantitation of tumor angiogenesis. Methods Mol Med (2003) 0.89
Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo. Prostate (2010) 0.84
Increased platelet storage time is associated with mitochondrial dysfunction and impaired platelet function. J Surg Res (2013) 0.82
Primate cerebellar granule cells exhibit a tonic GABAAR conductance that is not affected by alcohol: a possible cellular substrate of the low level of response phenotype. Front Neural Circuits (2013) 0.80
The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo. Prostate (2012) 0.80
Mechanisms of sulindac-induced apoptosis and cell cycle arrest. Cancer Lett (2005) 0.78
Low frequency flowmotion/(vasomotion) during patho-physiological conditions. Life Sci (2002) 0.77
High-throughput polyribosome fractionation. Nucleic Acids Res (2004) 0.77
Vertical arrays: microarrays of complex mixtures of nucleic acids. Methods Mol Biol (2006) 0.77
Purification of caveolae by affinity two-phase partitioning using biotinylated antibodies and NeutrAvidin-dextran. Anal Biochem (2004) 0.76
The roles of epithelial-mesenchymal interactions and the innate immune response on the tumorigenicity of human prostate carcinoma cell lines grown in immuno-compromised mice. In Vivo (2003) 0.76
Assessment of gene expression in many samples using vertical arrays. Nucleic Acids Res (2008) 0.75
Early Metabolic Flare in Squamous Cell Carcinoma after Chemotherapy is a Marker of Treatment Sensitivity In Vitro. Nucl Med Mol Imaging (2010) 0.75
From mRNA to tumor suppressor. Nat Genet (2004) 0.75
Microarray analysis using RNA arbitrarily primed PCR. Methods Mol Biol (2003) 0.75
Clinical nursing initiatives begin to show benefits. Am J Nurs (2014) 0.75
The experience of parents of children with primary lymphoedema. Int J Palliat Nurs (2002) 0.75
Survey of Doppler use in lymphoedema practitioners in the UK. Br J Community Nurs (2008) 0.75
Medical marijuana: a hazy state of affairs for nurses. Am J Nurs (2014) 0.75
Macrophage-mediated bystander effect triggered by tumor cell apoptosis. Mol Ther (2007) 0.75
Achieving optimum pain control in terminally ill patients at home. Practitioner (2007) 0.75